EUVIMEDEUVIMED entdecken
Crossref

Glia and CED-1/MEGF10 independently drive dopamine neurodegeneration in Parkinson’s disease models

German Rojas iD, Sneha Ray iD, Solomon Wossene iD, Irini Topalidou iD, Aakanksha Singhvi iD

Journal of Cell Biology · 04.01.2027 · 226 (1)

DOI: 10.1083/jcb.202505164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cell Biology, online erschienen am 12.11.2026. Verfasst von German Rojas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Basic Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA. Hauptthemen laut MEDLINE: Caenorhabditis elegans Proteins, Dopaminergic Neurons, Parkinson Disease, Neuroglia. Die Arbeit nennt 172 Literaturangaben. Gefördert von: Howard Hughes Medical Institute, NIH HHS, Ellison Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is marked by progressive dopamine neuron degeneration, but the phagocytic receptors and cells that clear neuronal corpses remain ill-defined. Moreover, while other cell types like glia, epithelia, and muscle are also impacted in PD, their roles in disease progression are unclear. We report that multiple nonneuronal cell types modulate dopamine neurodegeneration in Caenorhabditis elegans. Astrocyte-like CEPsh glia respond to neuronal stress and regulate dopamine biosynthesis enzyme CAT-2/TH and transporter DAT-1/SLC6A3. They are neurotoxic by downregulating neuroprotective dopamine levels. Degenerating dopamine neurons expose phosphatidylserine (PS) via the necrotic phospholipid scramblase ANOH-1/TMEM16F and ABC transporter CED-7/ABCA1. Epithelia and muscle cells then phagocytose dopamine neuron corpses and drive neuron death and clearance via the conserved PS receptor CED-1/Draper/MEGF10. Depleting ced-1 protects against loss of dopamine neurons and associated animal behaviors in a PD model. Evolutionary conservation of the underlying components and their effects across PD models suggests that multi-organ engagement may be a shared feature of dopamine neurodegeneration in PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caenorhabditis elegans ProteinsDopaminergic NeuronsParkinson DiseaseNeurogliaDopamineNerve DegenerationMembrane ProteinsAnimalsCaenorhabditis elegansDisease Models, AnimalPhagocytosisHumans

Substanzen

Caenorhabditis elegans ProteinsDopamineced-1 protein, C elegansMembrane Proteins

Autor:innen und Institutionen

  • Division of Basic Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Graduate Program in Neuroscience, University of Washington , Seattle, WA, USA.
  • Department of Neurobiology and Biophysics, University of Washington School of Medicine, Seattle, WA, USA.

ORCID-Profile: German Rojas, Sneha Ray, Solomon Wossene, Irini Topalidou, Aakanksha Singhvi

Förderung

  • Howard Hughes Medical Institute
  • NIH HHS
  • Ellison Foundation
  • Van Sloun Foundation
  • Esther A & Joseph Klingenstein Fund and the Simons Foundation
  • Brain Research Foundation
  • NIH/National Institute of Neurological Disorders and Stroke
  • Glenn Foundation

Zitieren

APA

Rojas, G., Ray, S., Wossene, S., Topalidou, I., & Singhvi, A. (2027). Glia and CED-1/MEGF10 independently drive dopamine neurodegeneration in Parkinson’s disease models. Journal of Cell Biology, 226(1). https://doi.org/10.1083/jcb.202505164

Vancouver

Rojas G, Ray S, Wossene S, Topalidou I, Singhvi A. Glia and CED-1/MEGF10 independently drive dopamine neurodegeneration in Parkinson’s disease models. Journal of Cell Biology. 2027;226(1). doi:10.1083/jcb.202505164

BibTeX
@article{Rojas2027,
  author = {Rojas, German and Ray, Sneha and Wossene, Solomon and Topalidou, Irini and Singhvi, Aakanksha},
  title = {Glia and CED-1/MEGF10 independently drive dopamine neurodegeneration in Parkinson’s disease models},
  journal = {Journal of Cell Biology},
  year = {2027},
  volume = {226},
  number = {1},
  doi = {10.1083/jcb.202505164}
}
Kostenlos starten →